Bryce Point Capital LLC Makes New $687,000 Investment in Option Care Health, Inc. $OPCH

Bryce Point Capital LLC acquired a new stake in Option Care Health, Inc. (NASDAQ:OPCH) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 24,737 shares of the company’s stock, valued at approximately $687,000. Option Care Health makes up approximately 0.8% of Bryce Point Capital LLC’s portfolio, making the stock its 5th biggest position.

A number of other institutional investors have also made changes to their positions in OPCH. Johnson Investment Counsel Inc. lifted its stake in shares of Option Care Health by 25.5% in the third quarter. Johnson Investment Counsel Inc. now owns 110,992 shares of the company’s stock worth $3,081,000 after acquiring an additional 22,536 shares in the last quarter. Oppenheimer Asset Management Inc. raised its position in shares of Option Care Health by 23.4% in the 3rd quarter. Oppenheimer Asset Management Inc. now owns 55,429 shares of the company’s stock valued at $1,539,000 after purchasing an additional 10,512 shares in the last quarter. Hantz Financial Services Inc. boosted its stake in shares of Option Care Health by 987.7% during the 3rd quarter. Hantz Financial Services Inc. now owns 1,414 shares of the company’s stock valued at $39,000 after buying an additional 1,284 shares during the last quarter. Cornerstone Planning Group LLC grew its position in shares of Option Care Health by 7,621.4% during the third quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock worth $30,000 after buying an additional 1,067 shares in the last quarter. Finally, Allianz Asset Management GmbH increased its stake in shares of Option Care Health by 18.2% in the third quarter. Allianz Asset Management GmbH now owns 42,416 shares of the company’s stock worth $1,177,000 after buying an additional 6,545 shares during the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.

Option Care Health Trading Down 2.4%

Shares of NASDAQ OPCH opened at $33.17 on Tuesday. Option Care Health, Inc. has a 12-month low of $24.24 and a 12-month high of $36.80. The company has a market cap of $5.27 billion, a price-to-earnings ratio of 26.33, a price-to-earnings-growth ratio of 2.03 and a beta of 0.84. The company has a current ratio of 1.56, a quick ratio of 1.05 and a debt-to-equity ratio of 0.85. The stock’s 50 day simple moving average is $33.27 and its 200 day simple moving average is $30.04.

Wall Street Analyst Weigh In

OPCH has been the topic of a number of research analyst reports. Jefferies Financial Group reiterated a “buy” rating and set a $37.00 price objective on shares of Option Care Health in a research note on Tuesday, January 13th. Weiss Ratings reiterated a “hold (c)” rating on shares of Option Care Health in a research note on Monday, December 29th. Barrington Research boosted their price objective on Option Care Health from $38.00 to $42.00 and gave the company an “outperform” rating in a report on Friday, January 16th. Citigroup reaffirmed an “outperform” rating on shares of Option Care Health in a report on Tuesday, January 13th. Finally, National Bankshares set a $37.00 price target on Option Care Health in a report on Tuesday, January 27th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have given a Hold rating to the company. According to MarketBeat, Option Care Health has an average rating of “Moderate Buy” and an average target price of $37.46.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.